Prostate cancer

04 May 2010

US reviews diabetes, heart risk with prostate drugs

The U.S. Food and Drug Administration is examining if certain hormone treatments for men with prostate cancer pose a greater risk of diabetes or heart problems than other therapies.

This article has not necessarily been edited by Health24.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.